Oral Cavity & Tongue Cancer
- Oral cavity cancer is almost always squamous cell carcinoma (SCC) arising from the lining of the mouth — most commonly the oral tongue and floor of mouth.
- Your job on imaging isn't to diagnose it (the surgeon already biopsied it). It's to map how deep and far it goes — especially depth of invasion, midline crossing, bone involvement, and nodes.
- MRI is the workhorse for the soft-tissue tongue; CT shines for mandibular bone and the staging neck.
- Two questions decide a lot of surgery: does it cross the midline, and does it touch the mandible or reach the tongue base.
The mouth is a small, crowded, salty cave, and yet it manages to be one of the more anatomically intimidating places in radiology. The oral cavity packs muscle, fat, bone, nerves, and a constantly-moving tongue into a space the size of a plum — and when a cancer shows up, all anyone wants to know is how much of that real estate it has quietly annexed. That mapping job is the whole point of imaging here.
What it is (and what it almost always is)
Roughly 90% of oral cavity malignancy is squamous cell carcinoma, born from the mucosa — the wet pink lining of the mouth. The classic risk factors are tobacco and alcohol, which together are far worse than either alone (think two bullies who are friends). It tends to show up as an ulcerated or thickened patch the dentist or ENT can literally see and poke. So by the time it lands on your worklist, the diagnosis is usually settled. You are the cartographer, not the detective.
The oral cavity proper runs from the lips back to the junction with the oropharynx. The big subsites: the oral tongue (the front two-thirds you can stick out — not the tongue base, which is oropharynx and a different beast), the floor of mouth, the gums (gingiva), the retromolar trigone (the little triangle of mucosa behind the last lower molar — small, sneaky, and a notorious troublemaker), the buccal mucosa (cheek lining), and the hard palate.
The tongue has a geographic border. The front two-thirds is oral tongue (oral cavity); the back third is tongue base (oropharynx). They look continuous on a scan but stage differently and behave differently, so always pin down which side of the line you're on.
How deep, how far: the questions imaging answers
The single most important number in modern oral cavity staging is depth of invasion (DOI) — literally how far the tumor burrows down from the normal mucosal surface, not just how wide it spreads across it. A flat, wide tumor can be less dangerous than a small, deep one, because depth tracks the risk of nodal spread. DOI is officially a pathology measurement, but on MRI you can estimate it and flag a tumor that's plunging rather than crawling.
After depth, you're hunting for the things that change the operation:
- Midline crossing. Does the oral tongue tumor stay on one side, or push past the central fatty septum to the other? Crossing midline can mean a bigger resection and threatens the blood and nerve supply to both halves of the tongue.
- Mandible involvement. Is the cancer just touching the jawbone (the surgeon can shave it) or invading the marrow (now you need to remove a segment of bone)? That distinction reshapes the whole surgery.
- Tongue base / extrinsic muscle reach. Spread backward into the tongue base or into the muscles that anchor the tongue affects whether the tongue can be saved.
- Neurovascular and nodal spread. Including the lingual neurovascular bundle and the lymph nodes of the neck.
Depth of invasion, midline crossing, and mandibular marrow invasion are the three findings that most often change the surgical plan. If you report nothing else clearly, report these.
How to image it
MRI is the star for the tongue itself. Tumor is usually intermediate-to-bright on T2 and enhances, standing out against the orderly, striated, fatty muscle of the normal tongue. Crucially, fat-suppressed T1 lets you see whether the dark marrow signal of the mandible has been replaced by tumor — your best read on marrow invasion. The catch: the mouth never holds still, and dental amalgam throws metal artifact like confetti, so motion and hardware can wreck your images.
CT carries the staging neck and the bone. It's fast (less motion), great for cortical bone erosion of the mandible, and it's how you survey the neck for nodes. A patient puffing out their cheeks ("blown-cheek" technique) can peel the buccal mucosa off the gums so a small cheek lesion isn't hiding in a collapsed space.
Where it spreads, and the traps
Oral cavity SCC loves the neck lymph nodes, and it tends to march in an orderly fashion to the upper neck levels first before going further. Even a clinically normal-feeling neck is often electively treated, because micrometastases hide well. For the actual node-by-node bookkeeping — sizes, necrosis, levels — lean on nodal levels and staging and the broader head and neck cancer staging framework.
A sneakier route is perineural tumor spread, where cancer creeps along a nerve like water wicking up a paper towel, traveling far from the primary and skipping normal tissue in between. The retromolar trigone is a classic launch pad toward the mandibular nerve. It's subtle, it's bad, and it has its own page worth reading.
Dental amalgam and motion are the great saboteurs of oral cavity MRI — streak and blur can mimic or bury a tumor. If signal looks weird right next to fillings, suspect artifact before you call a finding. And don't confuse the normal lingual septum and symmetric striated muscle for disease; learn what a normal tongue looks like first.
The one thing to carry out
Oral cavity cancer is a known SCC most of the time, so imaging earns its keep by measuring the spread, not naming the disease. Tell the surgeon how deep it goes, whether it crosses the midline, whether it has reached the mandibular marrow or the tongue base, and what the nodes are doing. Get those right and you've done the job — closely related is its downstairs neighbor, pharyngeal and laryngeal cancer, which plays by similar rules in a different room of the same house.